Add BrightSurf on Google Email

Colorectal cancer screenings remain low for people ages 45 to 49 despite guideline change

Researchers found that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the USPSTF lowered the recommended screening age to 45. Despite investigating unmet social needs, no significant differences were found in testing uptake for this early midlife cohort.

SourceUniversity of California - Los Angeles Health Sciences·JournalJNCI Journal of the National Cancer Institute·TypeData/statistical analysis·DateNov 18, 2025

ASTRO publishes first clinical guideline on radiation therapy for gastric cancer

The American Society for Radiation Oncology (ASTRO) has published its first clinical guideline on radiation therapy for gastric cancer. The guidelines provide evidence-based recommendations for the role of radiation therapy in multidisciplinary care, including patient selection, integration with systemic therapy and treatment delivery.

SourceAmerican Society for Radiation Oncology·JournalPractical Radiation Oncology·TypeSystematic review·DateNov 18, 2025

Fertility preservation for patients with cancer

A case study in CMAJ describes successful ovarian tissue preservation in a young woman with Hodgkin lymphoma, highlighting the need for improved access to fertility preservation services. The 'hub-and-spoke' model presented offers a potential solution to overcome geographical barriers and improve patient outcomes.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeCase study·DateNov 17, 2025

Computational deep dive surfaces unexplored world of cancer drug targets

A new computational tool called DeepTarget predicts direct and indirect targets of cancer drugs, revealing that small molecules can have different targets and effects depending on the disease and cell type. The study demonstrates the tool's superior performance in real-world scenarios, highlighting its potential to accelerate drug deve...

SourceSanford Burnham Prebys·Journalnpj Precision Oncology·TypeComputational simulation/modeling·DateNov 14, 2025

Nasal therapeutic vaccine for treating cervical cancer

Researchers at Chiba University have developed a nasal therapeutic vaccine targeting E7 oncoprotein, which is produced by high-risk strains of HPV associated with cervical cancer. The vaccine triggers an immune response in the cervical mucosa, providing local protection against pathogens and foreign particles.

SourceChiba University·JournalScience Translational Medicine·TypeExperimental study·DateNov 12, 2025

Human approach is hypothesized to be superior to technology for supportive cancer care according to new data in JNCCN

A recent study found that team-based clinic participants perceived significant improvements in patient care, whereas technology-based clinic participants saw limited benefits. The study highlights the importance of human interaction and values-centered care in supportive cancer care.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateNov 10, 2025

Landmark Global Decade Report reveals breakthroughs in advanced breast cancer but exposes a widening global equity gap

The ABC Global Decade Report 2015-2025 reveals significant advances in breast cancer care for some patients globally. However, persistent inequalities leave many behind. The report's findings drive the creation of the ABC Global Charter 2025-2035, aiming to improve equitable progress and transform care for everyone with ABC.

SourceAssociação Advanced Breast Cancer Global Alliance·JournalThe Breast·TypeObservational study·DateNov 5, 2025

Chinese Medical Journal study reveals GSTP1’s role in preventing ferroptosis and dox-induced heart injury

A study published in the Chinese Medical Journal identified GSTP1 as a key regulator that blocks JNK-driven ferroptosis, providing protection against DOX-induced cardiomyopathy. Overexpression of GSTP1 inhibited ferroptosis and improved DOX-induced heart injury.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateNov 5, 2025

Mass General Brigham researchers harness tumor cells to boost antitumor immunity in preclinical cancer models

Researchers at Mass General Brigham have developed a strategy to promote antitumor immunity by inducing cancer cells to produce an immune-activating molecule. This approach was shown to reduce tumor growth and improve survival in mouse models of aggressive melanoma, with potential applications beyond cancer therapies.

SourceMass General Brigham·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateNov 3, 2025

Americans have widespread misbeliefs about the cancer risks of alcohol, study finds

A new study found that more than half of American adults misunderstand the link between alcohol consumption and cancer. Alcohol drinkers are particularly likely to believe drinking has no effect on cancer risk. Correcting these misbeliefs may strengthen adherence to U.S. Surgeon General’s guidelines for lowering cancer risk.

Artificial intelligence takes the lead in revolutionizing cancer research explored at NFCR’s 2025 Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship.

Artificial intelligence is transforming cancer prevention, detection, and treatment by connecting technology with people. AI-driven public-health analytics, patient-doctor relationships, and diverse clinical research are crucial for delivering immediate benefit to patients, clinicians, and policymakers.

Folate receptor beta found in pediatric tumors may improve fluorescence-guided cancer surgery

Researchers discovered that folate receptor beta is widely expressed in various pediatric and adolescent solid tumors, making it a promising target for improving tumor surgery accuracy. Pafolacianine, a next-generation dye targeting folate receptors, shows promise as a tumor-agnostic imaging strategy for pediatric cancer surgery.

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateOct 20, 2025

Pathogenic germline variants in cancer susceptibility genes

Researchers identified 5.05% of individuals carrying pathogenic variants in key cancer susceptibility genes, highlighting a significant association between these genetic variations and increased cancer risk. The study suggests that more extensive genetic screening for these genes may be warranted to identify high-risk individuals.

SourceJAMA Network·JournalJAMA·DateOct 16, 2025